Patent ID: 9487816
Filing Date: 2016-11-08
CPC Classification: C12N,C12Q,C12Y,G01N

Claim Text:
1. A method of treating a human patient by distinguishing presence of influenza virus in a sample from presence of one or more other pathogens in the sample, the method comprising measuring enzymatic activity of neuraminidase (NA) in the sample under one or more differentiating conditions selected from the group consisting of NA enzymatic activity determination at a plurality of pH values, binding to anti-NanA antibody, size exclusion, hemagglutinin (HA) binding, chemical inhibition, and combinations thereof, wherein the one or more differentiating conditions is NA enzymatic activity determination at a plurality of pH values and the method comprises: (a) providing a biological sample obtained from the patient, wherein the sample is suspected of comprising influenza virus; (b) contacting the sample with a substrate for indicating NA enzymatic activity at a plurality of pH values ranging from about pH 4 to about pH 10, wherein NA acts on the substrate to elicit a measurable response; (c) measuring the response of step (b) at the plurality of pH values; (d) correlating the response at the plurality of pH values to determine relative NA enzymatic activity at the plurality of pH values, wherein (e) treating the patient with an antiviral drug when the presence of influenza virus in the sample is indicated.